Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19

T Struyf, JJ Deeks, J Dinnes… - Cochrane database …, 2022 - cochranelibrary.com
Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID‐19): a meta‐analysis of 27,492 patients

J Saniasiaya, MA Islam, B Abdullah - The Laryngoscope, 2021 - Wiley Online Library
Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences

CS von Bartheld, MM Hagen… - ACS chemical …, 2020 - ACS Publications
A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

[HTML][HTML] Key aspects in nutritional management of COVID-19 patients

A Fernández-Quintela, I Milton-Laskibar… - Journal of clinical …, 2020 - mdpi.com
This review deals with the relationship among nutrition, the immune system, and coronavirus
disease 2019 (COVID-19). The influence of nutrients and bioactive molecules present in …

[HTML][HTML] Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms-a …

E Mutiawati, M Fahriani, SS Mamada, JK Fajar… - …, 2021 - ncbi.nlm.nih.gov
Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Prevalence and characteristics of taste disorders in cases of COVID-19: a meta-analysis of 29,349 patients

J Saniasiaya, MA Islam… - … –Head and Neck Surgery, 2021 - journals.sagepub.com
Objective The purpose of this meta-analysis is to assess the pooled prevalence of taste
disorders and their subtypes in patients with COVID-19. Data Sources PubMed, Scopus …

Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19

CY Ho, M Salimian, J Hegert, J O'Brien, SG Choi… - JAMA …, 2022 - jamanetwork.com
Importance Loss of smell is an early and common presentation of COVID-19 infection.
Although it has been speculated that viral infection of olfactory neurons may be the culprit, it …

The association of “loss of smell” to COVID-19: a systematic review and meta-analysis

M Aziz, H Goyal, H Haghbin, WM Lee-Smith… - The American Journal of …, 2021 - Elsevier
Background The presence of olfactory dysfunction or “loss of smell” has been reported as an
atypical symptom in patients with coronavirus disease 2019 (COVID-19). We performed a …

Systematic review and meta-analysis of smell and taste disorders in COVID-19

TS Ibekwe, AJ Fasunla, AE Orimadegun - OTO open, 2020 - journals.sagepub.com
Objective Loss of smell and taste are considered potential discriminatory symptoms
indicating triaging for coronavirus disease 2019 (COVID-19) and early case identification …